Mentored Showcase


Presenting teams

Thank you to all the teams who submitted their projects. The following teams have been selected to present at the Mentored Showcase/Shark Tank on June 15 at 11:00am in the Genentech Hall Auditorium.

  • SmartDerm, UC Berkeley
  • Novel CSF Shunt Design to Better Diagnose and Predict Shunt Failure During Treatment for Hydrocephalus, UCLA
  • KIT: Kidney Injury Test, UC San Francisco

Honorable mentions

The following teams, while not selected, were ranked highly and received honorable mentions from the Project Review & Selection Committee:

  • Point-of-Care Bioimpedimetric Thromoboelastography, UC Davis
  • Otto, UC San Francisco



The Mentored Showcase will give teams the opportunity to work with a mentor and present their concept to a panel of judges from a range of areas of expertise. The winning team will receive a cash prize and the chance to present at the third Annual Rosenman Institute Symposium on June 22, 2016. The winning team will also receive the opportunity to get their company started with the help of QB3 and the Rosenman Institute.



The UCSF BIC Mentored Showcase is open to any UC-based students with a promising medical device idea or project that, if accepted and chosen, is able to present at the Innovations Summit on June 22 and is willing to invest the necessary time to work with QB3 and the Rosenman Institute to develop their idea into a marketable product.


Devices, diagnostics, and therapeutics, including Digital Health, projects at any stage of development that could benefit from specialized advising services are encouraged to apply. Therapeutics and devices can cover any medical problem where there is an unmet need for the potential for significant improvement over current treatments, diagnostics, or services.

Review criteria

Proposals were evaluated on:

  • Compelling unmet clinical need
  • Feasibility of concept and development plan
  • Likelihood for success in treating patients


Shuvo Roy, PhD
[email protected]
Professor, Dept. of Bioengineering and Therapeutic Sciences, UCSF
Director, BioDesign Lab
Engineering Lead, Surgical Innovations
Faculty Director, UC Berkeley/UCSF Master of Translational Medicine (MTM) Graduate Program

Submissions will be reviewed by a multidisciplinary internal review panel with input from external advisors who have agreed to confidentiality. All teams selected to present must be aware that their presentations will be open to the Symposium attendees.